Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Centene Corporation Common Stock (NY:CNC)

41.66 +0.57 (+1.39%)
Streaming Delayed Price Updated: 3:27 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
News headline image
3 Inflated Stocks We Keep Off Our Radar
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
Via StockStory
News headline image
Centene (CNC) Q4 2024 Earnings Transcript ↗
Centene (CNC) Q4 2024 Earnings Transcript 
Via The Motley Fool
News headline image
Centene (CNC) Q3 2024 Earnings Transcript ↗
Centene (CNC) Q3 2024 Earnings Transcript 
Via The Motley Fool
Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗
Via Chartmill
Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Stocks making big moves yesterday: Washington Trust Bancorp, Halliburton, CrowdStrike, DigitalOcean, and Centene
Check out the companies making headlines yesterday: Washington Trust Bancorp (NASDAQ:WASH): Regional bank Washington Trust Bancorp (NASDAQ:WASH) fell by 16.4... 
Via StockStory
News headline image
Why Centene (CNC) Stock Is Trading Up Today
What Happened? Shares of health coverage company Centene (NYSE:CNC) jumped 2.6% in the afternoon session after its competitor, UnitedHealth Group, reported a... 
Via StockStory
News headline image
UnitedHealth Group Surprises Wall Street. Is It Time to Load Up on the Beaten-Down Buffett Stock? ↗
A year after shocking the market by missing on earnings, UnitedHealth Group manages to delight. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
Wondering what's happening in today's S&P500 pre-market session? ↗
Via Chartmill
News headline image
2 S&P 500 Stocks with Competitive Advantages and 1 That Underwhelm
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
Alignment Healthcare, Centene, CVS Health, Elevance Health, and Clover Health Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ... 
Via StockStory
Topics Economy Stocks
Wondering what's happening in today's S&P500 pre-market session? ↗
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
Health Insurance Providers Stocks Q4 In Review: Centene (NYSE:CNC) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Centene (NYSE:CNC) and its peers. Upfr... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Top S&P500 movers in Monday's session ↗
Via Chartmill
Monday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Top S&P500 movers in Wednesday's session ↗
Via Chartmill
News headline image
2 Growth Stocks with All-Star Potential and 1 Facing Challenges
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
Vera Therapeutics develops biologic therapies for serious immunological diseases, with a pipeline targeting high-burden conditions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology to advance precision oncology solutions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
Praxis Precision Medicines develops therapies for central nervous system disorders, targeting unmet needs in neurology and psychiatry. 
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
3 Cash-Heavy Stocks That Fall Short
A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c... 
Via StockStory
News headline image
3 Reasons CNC is Risky and 1 Stock to Buy Instead
The past six months have been a windfall for Centene’s shareholders. The company’s stock price has jumped 52.4%, hitting $43.66 per share. This performance m... 
Via StockStory
News headline image
3 Cash-Producing Stocks We Find Risky
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
3 Value Stocks with Warning Signs
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.